Back to Search Start Over

Mutations associated with succinate dehydrogenase D-related malignant paragangliomas.

Authors :
Timmers, H.J.L.M.
Pacak, K.
Bertherat, J.
Lenders, J.W.M.
Duet, M.
Eisenhofer, G.
Stratakis, C.A.
Niccoli-Sire, P.
Tran, B.H.
Burnichon, N.
Gimenez-Roqueplo, A.P.
Timmers, H.J.L.M.
Pacak, K.
Bertherat, J.
Lenders, J.W.M.
Duet, M.
Eisenhofer, G.
Stratakis, C.A.
Niccoli-Sire, P.
Tran, B.H.
Burnichon, N.
Gimenez-Roqueplo, A.P.
Source :
Clinical Endocrinology; 561; 566; 0300-0664; 4; 68; ~Clinical Endocrinology~561~566~~~0300-0664~4~68~~
Publication Year :
2008

Abstract

Contains fulltext : 70804.pdf (publisher's version ) (Closed access)<br />OBJECTIVE: Hereditary paraganglioma (PGL) syndromes result from germline mutations in genes encoding subunits B, C and D of the mitochondrial enzyme succinate dehydrogenase (SDHB, SDHC and SDHD). SDHB-related PGLs are known in particular for their high malignant potential. Recently, however, malignant PGLs were also reported among a small minority of Dutch carriers of the SDHD founder mutation D92Y. The aim of the study was to investigate which SDHD mutations are associated with malignant PGL. DESIGN: Case histories; collaborative study between referral centres in France, the USA, and the Netherlands. PATIENTS: Six unrelated patients with metastatic PGLs of either sympathetic or parasympathetic origin. MEASUREMENTS: Assessment of SDHD mutations underlying malignant PGL. RESULTS: Germline SDHD mutations underlying metastatic PGL were G148D, Y114X, L85X, W43X, D92Y, and IVS2+5G-->A. CONCLUSION: Our findings indicate that malignant SDHD-related PGL is associated with several mutations besides D92Y.

Details

Database :
OAIster
Journal :
Clinical Endocrinology; 561; 566; 0300-0664; 4; 68; ~Clinical Endocrinology~561~566~~~0300-0664~4~68~~
Publication Type :
Electronic Resource
Accession number :
edsoai.on1284106922
Document Type :
Electronic Resource